We are live on
!
Find out more
CFM
Catalyst Funds Management Portfolio holdings
AUM
$591M
1-Year Est. Return
71.09%
This Fund
S&P 500
This Quarter
Est. Return
+18.75%
1 Year Est. Return
+71.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$362M
AUM Growth
-$20.4M
(-5.3%)
Cap. Flow
-$61.6M
Cap. Flow
% of AUM
-17%
Top 10 Holdings %
Top 10 Hldgs %
19.16%
Holding
737
New
289
Increased
45
Reduced
94
Closed
308
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$9.8M |
| 2 |
Amphenol
APH
|
+$6.39M |
| 3 |
Applovin
APP
|
+$5.63M |
| 4 |
CRH
CRH
|
+$3.85M |
| 5 |
Insmed
INSM
|
+$3.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rio Tinto
RIO
|
+$11.7M |
| 2 |
Pfizer
PFE
|
+$7.17M |
| 3 |
NVIDIA
NVDA
|
+$7.15M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$7.02M |
| 5 |
Mastercard
MA
|
+$5.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Financials | 14.89% |
| 3 | Industrials | 12.22% |
| 4 | Materials | 11.64% |
| 5 | Healthcare | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Lightwave Logic
LWLG
$932M
| $70.6K | 0.02% |
+56,900
| New | +$59.8K |
|
352
Stoneridge
SRI
$209M
| $70.4K | 0.02% |
+10,000
| New | +$49K |
|
|
TEAD
353
Teads Holding Co
TEAD
$75.2M
| $69.5K | 0.02% |
+28,043
| New | +$84.8K |
|
354
Organogenesis Holdings
ORGO
$308M
| $63K | 0.02% |
+17,200
| New | +$64.1K |
|
355
Sana Biotechnology
SANA
$885M
| $61.7K | 0.02% |
+22,600
| New | +$46.6K |
|
356
Green Plains
GPRE
$1.19B
| $61.3K | 0.02% |
10,170
-7,290
| -42% | -$32.1K |
|
|
VTYX
357
DELISTED
Ventyx Biosciences
VTYX
| $61K | 0.02% |
+28,500
| New | +$46K |
|
|
INZY
358
DELISTED
Inozyme Pharma
INZY
| $60K | 0.02% |
+15,000
| New | +$37.1K |
|
359
Amplify Energy
AMPY
$163M
| $58.9K | 0.02% |
+18,400
| New | +$54.7K |
|
360
Full House Resorts
FLL
$84.5M
| $57.8K | 0.02% |
+15,800
| New | +$52.9K |
|
361
Chegg
CHGG
$108M
| $57.2K | 0.02% |
+47,300
| New | +$43.7K |
|
|
GPMT
362
Granite Point Mortgage Trust
GPMT
$63.7M
| $57.1K | 0.02% |
+23,100
| New | +$51.9K |
|
363
Trevi Therapeutics
TRVI
$2.49B
| $56.3K | 0.02% |
+10,300
| New | +$64.1K |
|
|
HTT
364
High Templar Tech Ltd
HTT
$377M
| $55.9K | 0.02% |
17,815
-85
| -0.5% | -$236 |
|
|
RERE
365
ATRenew
RERE
$859M
| $55.8K | 0.02% |
16,855
+555
| +3% | +$1.44K |
|
366
Ring Energy
REI
$322M
| $55.3K | 0.02% |
+69,700
| New | +$59K |
|
367
SES AI
SES
$186M
| $55.3K | 0.02% |
+62,300
| New | +$52.3K |
|
|
ATYR
368
aTyr Pharma
ATYR
$46.4M
| $54.2K | 0.02% |
10,700
-7,253
| -40% | -$28.5K |
|
369
Wheels Up
UP
$220M
| $53.7K | 0.01% |
+2,510
| New | +$61.7K |
|
370
SmartRent
SMRT
$183M
| $50.8K | 0.01% |
51,300
+35,872
| +233% | +$32.1K |
|
371
Lexicon Pharmaceuticals
LXRX
$1.02B
| $50.8K | 0.01% |
+53,700
| New | +$34.8K |
|
|
AGEN
372
Agenus
AGEN
$249M
| $50.3K | 0.01% |
+11,000
| New | +$38.1K |
|
373
Atossa Therapeutics
ATOS
$22.8M
| $49.2K | 0.01% |
+3,953
| New | +$47.3K |
|
|
MPT
374
Medical Properties Trust
MPT
$2.89B
| $49.1K | 0.01% |
11,400
-41,420
| -78% | -$205K |
|
375
Caribou Biosciences
CRBU
$156M
| $48.8K | 0.01% |
+38,700
| New | +$38.1K |
|
Similar funds
BBL
BA
DPRC
FL
MW
SM
LBIM
MPW
Catalyst Funds Management's Q2 2025 Portfolio in Review
As of Q2 2025, Catalyst Funds Management held 737 positions worth $362M, down 5.3% from $382M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Catalyst Funds Management withdrew a net $61.6M in Q2 2025, closing 308 positions and reducing 94 holdings. Its most notable exit was Pfizer, an estimated $7.17M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
Against the trend, Catalyst Funds Management opened a new position in VanEck Gold Miners ETF worth $10.3M.
- Catalyst Funds Management's largest Q2 2025 buy was VanEck Gold Miners ETF: 197,400 shares worth $10.3M.
- Catalyst Funds Management added most to Applovin in Q2 2025, an estimated $5.63M increase.
- Catalyst Funds Management's biggest Q2 2025 reduction was Rio Tinto, cutting an estimated $11.7M.
- Catalyst Funds Management fully exited Pfizer in Q2 2025, selling an estimated $7.17M.
- Catalyst Funds Management's ten largest holdings make up 19% of its $362M portfolio in Q2 2025.
- Catalyst Funds Management opened 289 new positions and closed 308 in Q2 2025.
- Catalyst Funds Management's portfolio value fell 5.3% quarter-over-quarter to $362M.
Based on Catalyst Funds Management's 13F filing for Q2 2025, filed 12 Aug 2025.